Literature DB >> 18158270

Quality-of-life trajectories in epilepsy: a review of the literature.

Ann Jacoby1, Gus A Baker.   

Abstract

The potential psychosocial sequelae of epilepsy are well-documented, but it cannot be assumed that trajectories for quality of life (QOL) of people with epilepsy will inevitably follow its clinical course. In this article, we draw on available literature to suggest likely QOL trajectories associated with epilepsy and the broad range of disease-, patient-, and other-focused factors that appear important in determining them. We conclude that both the likely shape and time frame for QOL trajectories associated with particular clinical scenarios can be delineated, but that their shape can be altered by a much wider range of factors than those represented as epilepsy disease progression. We identify contributory factors currently relatively unexplored and highlight implications for treatment and areas for future research.

Entities:  

Mesh:

Year:  2007        PMID: 18158270     DOI: 10.1016/j.yebeh.2007.11.013

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  30 in total

1.  Disparities in NIH funding for epilepsy research.

Authors:  Kimford J Meador; Jacqueline French; David W Loring; Page B Pennell
Journal:  Neurology       Date:  2011-09-27       Impact factor: 9.910

Review 2.  Epilepsy: A Spectrum Disorder.

Authors:  Joseph I Sirven
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

3.  Social and Cognitive Outcome from Childhood-Onset Epilepsy: Do We Have Some Good News?

Authors:  William B Barr
Journal:  Epilepsy Curr       Date:  2017 Sep-Oct       Impact factor: 7.500

4.  Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys.

Authors:  J Alonso; G Vilagut; S Chatterji; S Heeringa; M Schoenbaum; T Bedirhan Üstün; S Rojas-Farreras; M Angermeyer; E Bromet; R Bruffaerts; G de Girolamo; O Gureje; J M Haro; A N Karam; V Kovess; D Levinson; Z Liu; M E Medina-Mora; J Ormel; J Posada-Villa; H Uda; R C Kessler
Journal:  Psychol Med       Date:  2010-06-16       Impact factor: 7.723

5.  Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece.

Authors:  Charitomeni Piperidou; Anna Karlovasitou; Nikolaos Triantafyllou; Evagelia Dimitrakoudi; Aikaterini Terzoudi; Eleni Mavraki; Grigorios Trypsianis; Konstantinos Vadikolias; Ioannis Heliopoulos; Dimitrios Vassilopoulos; Stavros Balogiannis
Journal:  Qual Life Res       Date:  2008-07-29       Impact factor: 4.147

Review 6.  Stigma in epilepsy.

Authors:  Kirsten M Fiest; Gretchen L Birbeck; Ann Jacoby; Nathalie Jette
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

Review 7.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

8.  Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.

Authors:  David Victorson; Jose E Cavazos; Gregory L Holmes; Anthony T Reder; Valerie Wojna; Cindy Nowinski; Deborah Miller; Sarah Buono; Allison Mueller; Claudia Moy; David Cella
Journal:  Epilepsy Behav       Date:  2013-12-20       Impact factor: 2.937

9.  Treating patients with medically resistant epilepsy.

Authors:  Gregory L Krauss; Michael R Sperling
Journal:  Neurol Clin Pract       Date:  2011-12

10.  Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model.

Authors:  Simon Borghs; Erin L Tomaszewski; Katarina Halling; Christine de la Loge
Journal:  Patient       Date:  2016-10       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.